Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The Norfolk and Norwich University Hospital (NNUH) heart failure team has won a national prize for their innovative monitoring system.

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

A new system involving heart failure nurses at a Norfolk hospital has seen device alert response times plummet from weeks to ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

OMRON Healthcare, a global leader in innovative home health monitoring solutions, has expanded its collaboration with Tricog Health, an AI-driven cardiac care company, to launch KeeboHealth – an ...

Emperor Emeritus Akihito entered the University of Tokyo Hospital in Bunkyo Ward of the capital on July 14 as a precaution to ...

Many women with serious underlying medical conditions like heart disease need birth control that won't make their conditions ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Recent reports highlight the potential dangers of certain supplements, including turmeric, green tea extract, and red yeast ...

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...

Memorial Using Tech to Help Patients Monitor Vitals at Home A 30-second, at-home test can alert those with pre-existing cardiac conditions to abnormalities within their heart before the onset of any ...